Adrenergic alpha-Agonists
"Adrenergic alpha-Agonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs that selectively bind to and activate alpha adrenergic receptors.
| Descriptor ID |
D000316
|
| MeSH Number(s) |
D27.505.519.625.050.100.100 D27.505.696.577.050.100.100
|
| Concept/Terms |
Adrenergic alpha-Agonists- Adrenergic alpha-Agonists
- Adrenergic alpha Agonists
- alpha-Agonists, Adrenergic
- Receptor Agonists, Adrenergic alpha
- Receptor Agonists, alpha-Adrenergic
- Agonists, alpha-Adrenergic Receptor
- Receptor Agonists, alpha Adrenergic
- alpha-Adrenergic Receptor Agonist
- Agonist, alpha-Adrenergic Receptor
- Receptor Agonist, alpha-Adrenergic
- alpha Adrenergic Receptor Agonist
- alpha-Adrenergic Receptor Agonists
- alpha Adrenergic Receptor Agonists
- Adrenergic alpha-Agonist
- Adrenergic alpha Agonist
- alpha-Agonist, Adrenergic
- alpha-Adrenergic Agonist
- Agonist, alpha-Adrenergic
- alpha Adrenergic Agonist
- alpha-Adrenergic Agonists
- Agonists, alpha-Adrenergic
- alpha Adrenergic Agonists
- Adrenergic alpha-Receptor Agonist
- Adrenergic alpha Receptor Agonist
- Agonist, Adrenergic alpha-Receptor
- alpha-Receptor Agonist, Adrenergic
- Adrenergic alpha-Receptor Agonists
- Adrenergic alpha Receptor Agonists
- Agonists, Adrenergic alpha-Receptor
- alpha-Receptor Agonists, Adrenergic
|
Below are MeSH descriptors whose meaning is more general than "Adrenergic alpha-Agonists".
Below are MeSH descriptors whose meaning is more specific than "Adrenergic alpha-Agonists".
This graph shows the total number of publications written about "Adrenergic alpha-Agonists" by people in this website by year, and whether "Adrenergic alpha-Agonists" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 1997 | 1 | 0 | 1 |
| 1998 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2002 | 1 | 0 | 1 |
| 2003 | 2 | 3 | 5 |
| 2004 | 0 | 2 | 2 |
| 2006 | 0 | 3 | 3 |
| 2008 | 3 | 3 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Adrenergic alpha-Agonists" by people in Profiles.
-
Mueller D, Cahill SP. Noradrenergic modulation of extinction learning and exposure therapy. Behav Brain Res. 2010 Mar 17; 208(1):1-11.
-
Kilic A, Javadov S, Karmazyn M. Estrogen exerts concentration-dependent pro-and anti-hypertrophic effects on adult cultured ventricular myocytes. Role of NHE-1 in estrogen-induced hypertrophy. J Mol Cell Cardiol. 2009 Mar; 46(3):360-9.
-
Nag S, Wang Q, Limbird LE, Mokha SS. Knockout of spinophilin, an endogenous antagonist of arrestin-dependent alpha2-adrenoceptor functions, enhances receptor-mediated antinociception yet does not eliminate sex-related differences. Behav Brain Res. 2009 Feb 11; 197(2):457-61.
-
Rodr?guez N, Vargas Vidot J, Panelli J, Col?n H, Ritchie B, Yamamura Y. GC-MS confirmation of xylazine (Rompun), a veterinary sedative, in exchanged needles. Drug Alcohol Depend. 2008 Aug 01; 96(3):290-3.
-
Thompson AD, Angelotti T, Nag S, Mokha SS. Sex-specific modulation of spinal nociception by alpha2-adrenoceptors: differential regulation by estrogen and testosterone. Neuroscience. 2008 Jun 02; 153(4):1268-77.
-
Palumbo DR, Sallee FR, Pelham WE, Bukstein OG, Daviss WB, McDERMOTT MP. Clonidine for attention-deficit/hyperactivity disorder: I. Efficacy and tolerability outcomes. J Am Acad Child Adolesc Psychiatry. 2008 Feb; 47(2):180-188.
-
Daviss WB, Patel NC, Robb AS, McDERMOTT MP, Bukstein OG, Pelham WE, Palumbo D, Harris P, Sallee FR. Clonidine for attention-deficit/hyperactivity disorder: II. ECG changes and adverse events analysis. J Am Acad Child Adolesc Psychiatry. 2008 Feb; 47(2):189-198.
-
Paladini CA, Beckstead MJ, Weinshenker D. Electrophysiological properties of catecholaminergic neurons in the norepinephrine-deficient mouse. Neuroscience. 2007 Feb 09; 144(3):1067-74.
-
Nag S, Mokha SS. Activation of alpha2-adrenoceptors in the trigeminal region produces sex-specific modulation of nociception in the rat. Neuroscience. 2006 Nov 03; 142(4):1255-62.
-
Morissette MR, Cook SA, Foo S, McKoy G, Ashida N, Novikov M, Scherrer-Crosbie M, Li L, Matsui T, Brooks G, Rosenzweig A. Myostatin regulates cardiomyocyte growth through modulation of Akt signaling. Circ Res. 2006 Jul 07; 99(1):15-24.